Key Takeaways DGX stock jumped 27.3% over 12 months, far exceeding the industry and the benchmark's performance. Quest Diagnostics' strength in Advanced Diagnostics supports growth across high-demand medical categories. New health plan deals and lab partnerships are expanding DGX's reach and boosting volume and revenue.Quest Diagnostics (DGX) has shown impressive momentum in the past year, with its shares rallying 27.3%. The performance outpaces the industry’s 5.9% rise and the S&P 500 composite’s 12.3% g ...

Key Takeaways DGX posted strong Q1 growth across brain health, oncology and women's health diagnostics. Strategic deals like LifeLabs and PathAI Diagnostics strengthen DGX's core and adjacent markets. DGX targets 3% annual cost savings with automation, Project Nova and GenAI partnerships.Quest Diagnostics Inc. (DGX) is investing in advanced diagnostics to deliver and scale innovative services that improve patient care and drive growth. The company’s growth strategy includes pursuing value-creating, strate ...